01 - 08 - 2025
News
October 16, 2024
Apollo appoint Dr Dipender Gill to the strategic advisory board
Dr Dipender Gill has joined Apollo Therapeutics strategic advisory board, bringing with him extensive knowledge and experience in leveraging human-centric evidence within drug discovery and development.
Dr Gill is a world-leading expert in genetic epidemiology including Mendelian randomization techniques.
More News
11 - 12 - 2024
Apollo Therapeutics Signs Exclusive Ex-China License From Sunshine Lake Pharma for Clinical-Stage FGF21 / GLP-1 Dual Receptor Agonist, a Therapeutic With Major Commercial Potential in Multiple Indications
View Article07 - 22 - 2024
Apollo Therapeutics and the University of Oxford enter into drug discovery and development collaboration
Apollo Therapeutics will inject capital and expertise into pipeline of potentially lifesaving medici
View Article